Yayın:
Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy

dc.contributor.authorGülay Büyükköroğlu
dc.contributor.authorGezgin, Seval
dc.contributor.authorBehiye Şenel
dc.contributor.authorEbru Başaran
dc.contributor.authorSeval Gezgin
dc.contributor.orcid0000-0002-5089-6007
dc.contributor.orcid0000-0001-9747-8307
dc.contributor.orcid0000-0003-2104-2069
dc.date.accessioned2025-11-13T11:47:51Z
dc.date.issued2016-05-30
dc.identifier.doi10.4314/tjpr.v15i5.1
dc.identifier.endpage895
dc.identifier.issn1596-5996
dc.identifier.issue5
dc.identifier.openalexW4249597374
dc.identifier.scopus2-s2.0-84971472949
dc.identifier.startpage895
dc.identifier.urihttps://hdl.handle.net/11421/7989
dc.identifier.urihttps://doi.org/10.4314/tjpr.v15i5.1
dc.identifier.volume15
dc.identifier.wos000376757300001
dc.language.isoen
dc.relation.ispartofTropical Journal of Pharmaceutical Research
dc.rightsopenAccess
dc.subjectLiposome
dc.subjectSonication
dc.subjectCationic liposome
dc.subjectChemistry
dc.subjectChromatography
dc.subjectMTT assay
dc.subjectPaclitaxel
dc.subjectCytotoxicity
dc.subjectPharmacology
dc.subjectCell
dc.subjectBiochemistry
dc.subjectIn vitro
dc.subjectCancer
dc.subjectMedicine
dc.subjectTransfection
dc.subject.sdg3
dc.titleDevelopment of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5012866347

Dosyalar

Koleksiyonlar